Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000086185 | SCV003440414 | pathogenic | not provided | 2022-08-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function. ClinVar contains an entry for this variant (Variation ID: 99767). This missense change has been observed in individuals with macular dystrophy (PMID: 14517959, 17698758, 23213274). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 298 of the BEST1 protein (p.Phe298Ser). |
Institute of Human Genetics, |
RCV004815164 | SCV005070639 | likely pathogenic | Retinal dystrophy | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000086185 | SCV000118329 | not provided | not provided | no assertion provided | not provided |